#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Friedreich's ataxia Immune thrombocytopenia Hodgkin's disease recurrent Hepatic angiosarcoma Neuroendocrine cell hyperplasia of infancy Myocarditis Fusarium infection Choroidal dystrophy Immunoglobulin G4 related disease Oesophageal adenocarcinoma Deafness neurosensory Chronic graft versus host disease in intestine Bone marrow disorder Cystic fibrosis respiratory infection suppression Osteosarcoma metastatic More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma – Treatment Cytokine release syndrome – Treatment Glycogen storage disease type I – Trials in Disease Usher’s syndrome – Diagnostics Mucopolysaccharidosis III – Trials in Disease Waldenstrom’s macroglobulinaemia – Treatment Osteosarcoma recurrent – Life with Disease Chronic granulomatous disease Crigler-Najjar syndrome – Life with Disease Bronchiolitis obliterans syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rbl012.2 Mepivacaine Hydrochloride Progesterone Ph. Eur. Haloperidol Decanoate Trehalose Dihydrate (Ph.eur.) Pervi-Fus SECRETIN SYNTHETIC HUMAN NALDEMEDINE Aluminium Hydroxide Gebasaxturev Ipn01194 Samuraciclib Propafenone Hydrochloride KETOROLAC Lurasidone Eftilagimod Alfa Specific Nucleic Acid Sna-Her1 Loperamide Hydrochloride Magnesium Stearate Charcoal, Activated More therapies…

    Learn about Your Condition

    Dyspepsia Encephalopathy neonatal Lung adenocarcinoma Infant sedation Bone sarcoma Neoplasm malignant Pancreatitis relapsing Intracranial calcification Familial hypertriglyceridaemia Agitation postoperative Vestibular disorder Lichen sclerosus Lymphoedema Anal squamous cell carcinoma Myelodysplastic syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A Study to Test How Well PKN605 Works and How Safe It Is in Patients with Atrial Fibrillation

    Recruiting

    2 1
    Investigated Diseases:
    • Atrial fibrillation
    Germany The Netherlands

  • A Study of Amivantamab and Lazertinib for Adults with EGFR-Mutated Advanced or Metastatic Non-Small Cell Lung Cancer

    Recruiting

    2 1 1
    Investigated Drugs:
    • Amivantamab
    • Lazertinib
    Belgium Finland France Germany Greece Italy +3

  • A Study of Fluvoxamine for Reducing Fatigue in Patients with Post-COVID Condition

    Recruiting

    3 1 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    The Netherlands

  • Comparing hysteroscopic surgery to mifepristone and misoprostol treatment for early pregnancy loss in women under 10 weeks of pregnancy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Mifepristone
    • Misoprostol
    Belgium

  • A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

    Recruiting

    3 1 1
    Investigated Drugs:
    • Depemokimab
    • Salbutamol Sulfate
    Belgium Croatia Denmark France Germany Hungary +8

  • A study of guanabenz acetate for children with vanishing white matter disease who started treatment in early childhood

    Recruiting

    1 1 1
    Investigated Drugs:
    • Guanabenz Acetate
    The Netherlands
Previous Page
1 … 100 101 102 103 104 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!